Global Installed Base of Smart City Cameras with an AI Chipset to Reach Over 350 Million in 2025
Security Cameras with AI will be the smart city norm for applications such as intelligent…
Security Cameras with AI will be the smart city norm for applications such as intelligent…
LJUBLJANA, Slovenia, April 1, 2021 /PRNewswire/ — Trace Alliance is pleased to announce the new…
NEW YORK, April 1, 2021 /PRNewswire/ — DeFine Art has completed the biggest video NFT…
DANVILLE, Calif., Apr. 1, 2021 /PRNewswire-PRWeb/ — Glance Inc today announced AI Sparks for their top-ranked…
NACKA STRAND, Sweden, April 1, 2021 /PRNewswire/ — Hexagon AB, a global leader in sensor,…
SOLNA, Sweden, April 1, 2021 /PRNewswire/ — Loomis’ Annual Report and Sustainability Report for 2020…
Designed to affordably scale as a business grows, new tiered offering of the OptimalCloud IAM…
KIELPIN, Poland, April 01, 2021 (GLOBE NEWSWIRE) — Celon Pharma S.A. today announced the successful…
Basel, Switzerland, April 01, 2021 Basilea Pharmaceutica Ltd. (SIX: BSLN) today announced the successful closing…
Allschwil, Switzerland – April 1, 2021 Idorsia Ltd (SIX: IDIA) today issued the formal Notice…
– Applications are supported by positive PROTECTIVE-2 Phase 3 data demonstrating that plinabulin in combination…
SAN DIEGO, March 31, 2021 (GLOBE NEWSWIRE) — Solid tumors comprise about 90% of all…
HALIFAX, Nova Scotia, March 31, 2021 (GLOBE NEWSWIRE) — MedMira Inc. (MedMira) (TSXV: MIR), reported…
SOUTH SAN FRANCISCO, Calif., March 31, 2021 (GLOBE NEWSWIRE) — Applied Molecular Transport Inc. (Nasdaq:…
COLUMBUS, Ohio, March 31, 2021 (GLOBE NEWSWIRE) — Green Growth Brands Inc. (CSE: GGB) (OTCQB:…
FDA approves Sarclisa® (isatuximab) in combination with carfilzomib and dexamethasone for patients with relapsed or…
TORONTO, CHICAGO and MONTREAL, March 31, 2021 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals Inc. (the “Company”…
— Ultragenyx Collaboration and License Agreement for Setrusumab in Osteogenesis Imperfecta —— Further Strengthened Management…
In 2020, advanced two product candidates into Phase 1/2 clinical trials while strengthening Board of…
DELRAY BEACH, Fla., March 31, 2021 (GLOBE NEWSWIRE) — AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx”…